Autonomix Medical (NASDAQ:AMIX – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.
Earnings & Valuation
This table compares Autonomix Medical and KORU Medical Systems”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Autonomix Medical | N/A | N/A | -$15.43 million | ($12.93) | -0.23 |
| KORU Medical Systems | $28.52 million | 5.96 | -$13.74 million | ($0.25) | -14.84 |
KORU Medical Systems has higher revenue and earnings than Autonomix Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Autonomix Medical | N/A | -212.48% | -161.13% |
| KORU Medical Systems | -37.42% | -24.60% | -16.87% |
Institutional & Insider Ownership
10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by company insiders. Comparatively, 25.6% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Autonomix Medical and KORU Medical Systems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Autonomix Medical | 0 | 0 | 1 | 0 | 3.00 |
| KORU Medical Systems | 0 | 1 | 3 | 1 | 3.00 |
Autonomix Medical currently has a consensus price target of $28.00, suggesting a potential upside of 845.95%. KORU Medical Systems has a consensus price target of $4.70, suggesting a potential upside of 26.68%. Given Autonomix Medical’s higher probable upside, analysts plainly believe Autonomix Medical is more favorable than KORU Medical Systems.
Summary
KORU Medical Systems beats Autonomix Medical on 8 of the 12 factors compared between the two stocks.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
